Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: iGate Research | PRODUCT CODE: 1094391

Cover Image

PUBLISHER: iGate Research | PRODUCT CODE: 1094391

Liquid Biopsy Market, Impact of COVID-19, Initiatives, Funding, Major Deals, Company Profiles and Recent Developments - Global Forecast to 2030

PUBLISHED:
PAGES: 611 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3490
PDF (Enterprise License)
USD 4390

Add to Cart

The global liquid biopsy market is predicted to surpass US$ 11 Billion by 2030. The advantages of liquid biopsy over solid tumor biopsy, rising prevalence of cancer, increasing preference for non-invasive procedures, growing public and private funding to support research activities in the field of liquid biopsy and favorable government initiatives, are some of the factors expected to propel the growth of liquid biopsy market in the coming years. Some of the key factors inhibiting the growth of liquid biopsy market includes, clinical utility challenges, lack of sensitivity and specificity of liquid biopsy tests and unclear reimbursement & regulation scenario.

Liquid biopsy tests are executed to understand the molecular aspects of cancer across the healthcare and research settings, such as hospitals, physicians, pathological and research laboratories. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis & detection, characterization of new lesions, drug & therapeutic target identifications for cancer treatment are some advantages of liquid biopsies, which improve the safety and efficiency of cancer therapy for patients.

Impact of COVID-19 on Global Liquid Biopsy Market

The COVID-19 outbreak has become a global stress test. As the number of people infected with the virus continues to rise around the world, uncertainties about global economic growth increases. The COVID-19 disease has infected around 532 Million people worldwide. Globally the death toll has reached 6,311,594 according to the latest statistics from the Worldometers (as of May 31, 2022). The number is still growing, and the duration of the pandemic is still difficult to predict. The reactions to the COVID-19 pandemic and its effects on societies and economies around the world cannot be understated. The COVID-19 global pandemic has restricted the growth rate of the liquid biopsy market to some extent during 2020-2021. However, many countries have taken strict measures to combat the coronavirus, such as mass vaccination program, social distancing, use of masks, etc. Hence, we expect that the physicians/surgeons will see an increase in influx of patients, hence driving the liquid biopsy market growth.

Recent Developments

  • In March 2022, the Japanese Ministry of Health, Labour and Welfare granted regulatory approval of Guardant360 CDx, a liquid biopsy test for tumor mutation profiling, also known as comprehensive genomic profiling, in patients with advanced solid tumors.
  • In February 2022, Labcorp, a leading global life sciences company, closed its acquisition of Personal Genome Diagnostics Inc., a leader in cancer genomics with a portfolio of comprehensive liquid biopsy and tissue-based products.
  • In July 2021, Biocept, Inc. was awarded a South Korean Patent for its Primer-Switch technology, which detects rare mutations in circulating tumor DNA (ctDNA) using real-time PCR and associated analysis methods.
  • In March 2021, Lucence announced a partnership with Waseda University in Japan to develop a novel high-speed liquid biopsy laser-based imaging platform for early cancer detection.
  • In February 2021, Guardant Health, Inc. announced the availability of Guardant Reveal, the first blood-only liquid biopsy test for the detection of residual and recurrent disease from a simple blood draw.

Global Liquid Biopsy Market & Forecast - by Circulating Biomarker

  • Based on circulating biomarkers, in 2021, the circulating tumor cells (CTCs) segment captured largest share of the liquid biopsy market.
  • The circulating tumor DNA (ctDNA) is the 2nd largest segment of the liquid biopsy market.
  • The extracellular vesicles (EVs) segment is the fastest growing segment during the forecast period.

Global Liquid Biopsy Market & Forecast - by Products

  • On the basis of product, the Kits and Consumables segment is expected to account for largest share of the liquid biopsy market.
  • The instruments segment is likely to witness highest growth in the global liquid biopsy market.
  • The services segment captured least share of the liquid biopsy market.

Global Liquid Biopsy Market & Forecast - by Application

  • The global liquid biopsy market, by application, is being dominated by oncology application.
  • Lung cancer and breast cancer accounts for largest share of the liquid biopsy oncology market.
  • The non-cancer application segment is expected to be the fastest-growing segment in the market during the forecast period.

Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application

  • On the basis of clinical application, the therapy selection segment is expected to account for largest share of the liquid biopsy market throughout the forecast period.
  • Treatment monitoring captured second highest share of the liquid biopsy market in 2021, being followed by the early cancer screening application.
  • Recurrence monitoring captured least share of the liquid biopsy market.

Global Liquid Biopsy Market & Forecast - by End User

  • In 2021, Reference laboratories form the largest and fastest-growing end-user segment of the liquid biopsy market.
  • Hospital and Physician laboratories occupied second highest share of the liquid biopsy market in 2021, being followed by Academic and Research Centers.

Global Liquid Biopsy Market & Forecast - by Sample Type

  • Blood is the most widely used sample type and is expected to remain the largest market during the forecasting period as well.
  • The urine sample segment is anticipated to witness noticeable growth throughout the forecast period.

Liquid Biopsy Market & Forecast - Regional Analysis

  • North America accounted for largest share of the global liquid biopsy market in 2021.
  • In 2021, Europe captured second largest share of the global liquid biopsy market.
  • In Europe, Germany and France are the leading market for liquid biopsy.
  • Asia pacific is the fastest growing market for liquid biopsy.
  • In Asia Pacific, Japan and China are the leading market for liquid biopsy.
  • Latin America is the fourth largest market for liquid biopsy, being followed by Middle East & Africa.

iGATE RESEARCH, report titled "Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End Users, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Impact of COVID-19, Initiatives, Funding, Major Deals, Company Profiles and Recent Developments - Global Forecast to 2030" provides a comprehensive assessment of the fast-evolving, high-growth Global Liquid Biopsy Market.

This 611 Page report with 118 Figures and 7 Tables has been analyzed from 16 viewpoints:

1. Global Liquid Biopsy Market & Forecast (2016 - 2030)

2. Impact of COVID-19 on Global Liquid Biopsy Market

3. Global Liquid Biopsy Market Share & Forecast (2016 - 2030)

4. Global Liquid Biopsy Market & Forecast - by Circulating Biomarker (2016 - 2030)

5. Global Liquid Biopsy Market & Forecast - by Product (2016 - 2030)

6. Global Liquid Biopsy Market & Forecast - by Application (2016 - 2030)

7. Global Liquid Biopsy Oncology Market & Forecast - By Cancer Types (2016 - 2030)

8. Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application (2016 - 2030)

9. Global Liquid Biopsy Market & Forecast - by End User (2016 - 2030)

10. Global Liquid Biopsy Market & Forecast - by Sample Type (2016 - 2030)

11. Liquid Biopsy Market & Forecast - Regional Analysis (2016 - 2030)

12. Liquid Biopsy Market Share & Forecast - Geographical Analysis (2016 - 2030)

13. Liquid Biopsy Initiatives

14. Liquid Biopsy Companies Financing Details

15. 35 Company Profiles - Recent Developments / Initiatives, Major Deals

16. Global Liquid Biopsy Market - Driving Factors & Challenges

Global Liquid Biopsy Market & Forecast - by Circulating Biomarker

1. Circulating Tumor Cells (CTCs)

2. Circulating Tumor DNA (ctDNA)

3. Cell-Free DNA (cfDNA)

4. Extracellular Vesicles (EVs)

5. Other Circulating Biomarkers

Global Liquid Biopsy Market & Forecast - by Product

1. Kits and Consumables

2. Instruments

3. Services

Global Liquid Biopsy Market & Forecast - by Application

1. Oncology Application

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Gastrointestinal Cancer
  • Leukaemia
  • Others

2. Non-Cancer Application

Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application

1. Therapy Selection

2. Treatment Monitoring

3. Early Cancer Screening

4. Recurrence Monitoring

Global Liquid Biopsy Market & Forecast - by End User

1. Reference Laboratories

2. Hospitals and Physician Laboratories

3. Academic and Research Centers

4. Other End Users

Global Liquid Biopsy Market & Forecast - by Sample Type

1. Blood Sample

2. Urine Sample

3. Other Fluids Sample

Liquid Biopsy Market & Forecast - Regional Analysis

1. North America

  • United States
  • Canada

2. Asia Pacific

  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia Pacific

3. Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Rest of Europe

4. Middle East & Africa

  • UAE
  • Saudi Arabia
  • Egypt
  • Rest of Middle East & Africa

5. Latin America

Liquid Biopsy Market - Company Profiles, Recent Developments / Initiatives, Major Deals

1. Personal Genome Diagnostics

2. Guardant Health, Inc.

3. Pathway Genomics (Now OME CARE)

4. RainDance Technologies (Acquired by Bio-Rad Laboratories, Inc.)

5. Cardiff Oncology (Previously Trovagene, Inc.)

6. LungLife AI (Formerly Cynvenio Biosystems, Inc.)

7. Biocept, Inc.

8. ANGLE plc

9. MDxHealth

10. Biolidics Limited (Formerly Clearbridge Biomedics Pte Ltd)

11. Exosome Diagnostics, Inc. (Acquired by Bio-Techne Corporation)

12. Foundation Medicine, Inc

13. Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)

14. Genomic Health (Now Part of Exact Sciences Corp)

15. Myriad Genetics, Inc

16. Thermo Fisher Scientific, Inc

17. QIAGEN NV

18. Bio-Rad Laboratories, Inc

19. Menarini-Silicon Biosystems

20. GRAIL

21. NeoGenomics, Inc.

22. DiaCarta, Inc.

23. OncoCell MDx (Now Immunis.AI)

24. C2i Genomics

25. Biodesix

26. Freenome

27. Inivata

28. CellMax Life

29. Rarecyte Inc.

30. Saga Diagnostics

31. Thrive Earlier Detection Corp. (Acquired by Exact Sciences Corp.)

32. Lucence Diagnostics Pte Ltd

33. Karius, Inc.

34. Clinical Genomics Technologies Pty Ltd (CG)

35. Elypta

Data Sources

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Table of Contents

1. Executive Summary

2. Impact of COVID-19 on Global Liquid Biopsy Market

3. Global Liquid Biopsy Market & Forecast (2016 - 2030)

4. Global Liquid Biopsy Market Share & Forecast (2016 - 2030)

  • 4.1 Global Liquid Biopsy Market Share & Forecast - by Circulating Biomarker
  • 4.2 Global Liquid Biopsy Market Share & Forecast - by Product
  • 4.3 Global Liquid Biopsy Market Share & Forecast - by Application
  • 4.4 Global Liquid Biopsy Oncology Market Share & Forecast - by Clinical Application
  • 4.5 Global Liquid Biopsy Oncology Market Share & Forecast - By Cancer Types
  • 4.6 Global Liquid Biopsy Market Share & Forecast - by End User
  • 4.7 Global Liquid Biopsy Market Share & Forecast - by Sample Type
  • 4.8 Liquid Biopsy Market Share & Forecast - Regional Analysis
  • 4.9 Liquid Biopsy Market Share & Forecast - Country Wise Analysis

5. Global Liquid Biopsy Market & Forecast - by Circulating Biomarker (2016 - 2030)

  • 5.1 Global Liquid Biopsy - Circulating Tumor Cells (CTCs) Market & Forecast
  • 5.2 Global Liquid Biopsy - Circulating Tumor DNA (ctDNA) Market & Forecast
  • 5.3 Global Liquid Biopsy - Cell-Free DNA (cfDNA) Market & Forecast
  • 5.4 Global Liquid Biopsy - Extracellular Vesicles (EVs) Market & Forecast
  • 5.5 Global Liquid Biopsy - Other Circulating Biomarkers Market & Forecast

6. Global Liquid Biopsy Market & Forecast - by Product (2016 - 2030)

  • 6.1 Global Liquid Biopsy - Kits and Consumables Market & Forecast
  • 6.2 Global Liquid Biopsy - Instruments Market & Forecast
  • 6.3 Global Liquid Biopsy - Services Market & Forecast

7. Global Liquid Biopsy Market & Forecast - by Application (2016 - 2030)

  • 7.1 Global Liquid Biopsy - Oncology Application Market & Forecast
  • 7.2 Global Liquid Biopsy Oncology Market & Forecast - By Cancer Types
    • 7.2.1 Lung Cancer Liquid Biopsy Market & Forecast
    • 7.2.2 Breast Cancer Liquid Biopsy Market & Forecast
    • 7.2.3 Colorectal Cancer Liquid Biopsy Market & Forecast
    • 7.2.4 Prostate Cancer Liquid Biopsy Market & Forecast
    • 7.2.5 Gastrointestinal Cancer Liquid Biopsy Market & Forecast
    • 7.2.6 Leukaemia Liquid Biopsy Market & Forecast
    • 7.2.7 Others Liquid Biopsy Market & Forecast
  • 7.3 Global Liquid Biopsy - Non-Cancer Application Market & Forecast

8. Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application (2016 - 2030)

  • 8.1 Global Liquid Biopsy Oncology Application - Therapy Selection Market & Forecast
  • 8.2 Global Liquid Biopsy Oncology Application - Treatment Monitoring Market & Forecast
  • 8.3 Global Liquid Biopsy Oncology Application - Early Cancer Screening Market & Forecast
  • 8.4 Global Liquid Biopsy Oncology Application - Recurrence Monitoring Market & Forecast

9. Global Liquid Biopsy Market & Forecast - by End User (2016 - 2030)

  • 9.1 Global Liquid Biopsy - Reference Laboratories Market & Forecast
  • 9.2 Global Liquid Biopsy - Hospitals and Physician Laboratories Market & Forecast
  • 9.3 Global Liquid Biopsy - Academic and Research Centers Market & Forecast
  • 9.4 Global Liquid Biopsy - Other End Users Market & Forecast

10. Global Liquid Biopsy Market & Forecast - by Sample Type (2016 - 2030)

  • 10.1 Global Liquid Biopsy - Blood Sample Market & Forecast
  • 10.2 Global Liquid Biopsy - Urine Sample Market & Forecast
  • 10.3 Global Liquid Biopsy - Other Fluids Sample Market & Forecast

11. Liquid Biopsy Market & Forecast - Regional Analysis (2016 - 2030)

  • 11.1 North America Liquid Biopsy Market & Forecast
  • 11.2 Asia Pacific Liquid Biopsy Market & Forecast
  • 11.3 Europe Liquid Biopsy Market & Forecast
  • 11.4 Latin America Liquid Biopsy Market & Forecast
  • 11.5 Middle East & Africa Liquid Biopsy Market & Forecast

12. Liquid Biopsy Market Share & Forecast - Geographical Analysis (2016 - 2030)

  • 12.1 North America Liquid Biopsy Market & Forecast
    • 12.1.1 United States Liquid Biopsy Market & Forecast
    • 12.1.2 Canada Liquid Biopsy Market & Forecast
  • 12.2 Asia Pacific Liquid Biopsy Market & Forecast
    • 12.2.1 South Korea Liquid Biopsy Market & Forecast
    • 12.2.2 Japan Liquid Biopsy Market & Forecast
    • 12.2.3 China Liquid Biopsy Market & Forecast
    • 12.2.4 India Liquid Biopsy Market & Forecast
    • 12.2.5 Australia Liquid Biopsy Market & Forecast
    • 12.2.6 Rest of Asia Pacific Liquid Biopsy Market & Forecast
  • 12.3 Europe Liquid Biopsy Market & Forecast
    • 12.3.1 Germany Liquid Biopsy Market & Forecast
    • 12.3.2 France Liquid Biopsy Market & Forecast
    • 12.3.3 United Kingdom Liquid Biopsy Market & Forecast
    • 12.3.4 Italy Liquid Biopsy Market & Forecast
    • 12.3.5 Spain Liquid Biopsy Market & Forecast
    • 12.3.6 Rest of Europe Liquid Biopsy Market & Forecast
  • 12.4 Middle East & Africa Liquid Biopsy Market & Forecast
    • 12.4.1 UAE Liquid Biopsy Market & Forecast
    • 12.4.2 Saudi Arabia Liquid Biopsy Market & Forecast
    • 12.4.3 Egypt Liquid Biopsy Market & Forecast
    • 12.4.4 Rest of Middle East & Africa Liquid Biopsy Market & Forecast
  • 12.5 Latin America Liquid Biopsy Market & Forecast

13. Liquid Biopsy Initiatives

14. Liquid Biopsy Companies Financing Details

15. Company Profiles

  • 15.1 Personal Genome Diagnostics (Acquired by Labcorp)
    • 15.1.1 Company Overview
    • 15.1.2 Recent Developments / Initiatives
  • 15.2 Guardant Health, Inc.
    • 15.2.1 Company Overview
    • 15.2.2 Recent Developments / Initiatives
  • 15.3 Pathway Genomics (Now OME CARE)
    • 15.3.1 Company Overview
    • 15.3.2 Recent Developments / Initiatives
  • 15.4 RainDance Technologies (Acquired by Bio-Rad Laboratories, Inc.)
    • 15.4.1 Company Overview
    • 15.4.2 Recent Developments / Initiatives
  • 15.5 Cardiff Oncology (Previously Trovagene, Inc.)
    • 15.5.1 Company Overview
    • 15.5.2 Recent Developments / Initiatives
  • 15.6 LungLife AI (Formerly Cynvenio Biosystems, Inc.)
    • 15.6.1 Company Overview
    • 15.6.2 Recent Developments / Initiatives
  • 15.7 Biocept, Inc.
    • 15.7.1 Company Overview
    • 15.7.2 Recent Developments / Initiatives
  • 15.8 ANGLE plc
    • 15.8.1 Company Overview
    • 15.8.2 Recent Developments / Initiatives
  • 15.9 MDxHealth
    • 15.9.1 Company Overview
    • 15.9.2 Recent Developments / Initiatives
  • 15.10 Biolidics Limited (Formerly Clearbridge Biomedics Pte Ltd)
    • 15.10.1 Company Overview
    • 15.10.2 Recent Developments / Initiatives
  • 15.11 Exosome Diagnostics, Inc. (Acquired by Bio-Techne Corporation)
    • 15.11.1 Company Overview
    • 15.11.2 Recent Developments / Initiatives
  • 15.12 Foundation Medicine, Inc.
    • 15.12.1 Company Overview
    • 15.12.2 Recent Developments / Initiatives
  • 15.13 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)
    • 15.13.1 Company Overview
    • 15.13.2 Recent Developments / Initiatives
  • 15.14 Genomic Health (Now Part of Exact Sciences Corp)
    • 15.14.1 Company Overview
    • 15.14.2 Recent Developments / Initiatives
  • 15.15 Myriad Genetics, Inc.
    • 15.15.1 Company Overview
    • 15.15.2 Recent Developments / Initiatives
  • 15.16 Thermo Fisher Scientific, Inc.
    • 15.16.1 Company Overview
    • 15.16.2 Recent Developments / Initiatives
  • 15.17 QIAGEN NV
    • 15.17.1 Company Overview
    • 15.17.2 Recent Developments / Initiatives
  • 15.18 Bio-Rad Laboratories, Inc.
    • 15.18.1 Company Overview
    • 15.18.2 Recent Developments / Initiatives
  • 15.19 Menarini-Silicon Biosystems
    • 15.19.1 Company Overview
    • 15.19.2 Recent Developments / Initiatives
  • 15.20 GRAIL
    • 15.20.1 Company Overview
    • 15.20.2 Recent Developments / Initiatives
  • 15.21 NeoGenomics, Inc.
    • 15.21.1 Company Overview
    • 15.21.2 Recent Developments / Initiatives
  • 15.22 DiaCarta, Inc.
    • 15.22.1 Company Overview
    • 15.22.2 Recent Developments / Initiatives
  • 15.23 OncoCell MDx (Now Immunis.AI)
    • 15.23.1 Company Overview
    • 15.23.2 Recent Developments / Initiatives
  • 15.24 C2i Genomics
    • 15.24.1 Company Overview
    • 15.24.2 Recent Developments / Initiatives
  • 15.25 Biodesix
    • 15.25.1 Company Overview
    • 15.25.2 Recent Developments / Initiatives
  • 15.26 Freenome
    • 15.26.1 Company Overview
    • 15.26.2 Recent Developments / Initiatives
  • 15.27 Inivata
    • 15.27.1 Company Overview
    • 15.27.2 Recent Developments / Initiatives
  • 15.28 CellMax Life
    • 15.28.1 Company Overview
    • 15.28.2 Recent Developments / Initiatives
  • 15.29 Rarecyte Inc.
    • 15.29.1 Company Overview
    • 15.29.2 Recent Developments / Initiatives
  • 15.30 Saga Diagnostics
    • 15.30.1 Company Overview
    • 15.30.2 Recent Developments / Initiatives
  • 15.31 Thrive Earlier Detection Corp. (Acquired by Exact Sciences Corp.)
    • 15.31.1 Company Overview
    • 15.31.2 Recent Developments / Initiatives
  • 15.32 Lucence Diagnostics Pte Ltd
    • 15.32.1 Company Overview
    • 15.32.2 Recent Developments / Initiatives
  • 15.33 Karius, Inc.
    • 15.33.1 Company Overview
    • 15.33.2 Recent Developments / Initiatives
  • 15.34 Clinical Genomics Technologies Pty Ltd (CG)
    • 15.34.1 Company Overview
    • 15.34.2 Recent Developments / Initiatives
  • 15.35 Elypta
    • 15.35.1 Company Overview
    • 15.35.2 Recent Developments / Initiatives

16. Global Liquid Biopsy Market - Driving Factors

  • 16.1 Rising Applications of Liquid Biopsy Expected to Boost Liquid Biopsy Market
  • 16.2 Personalized Medicine to Spur Use of Liquid Biopsy Tests in Clinical Practice
  • 16.3 Rising Aging Population and Cancer Incidences to Drive Liquid Biopsy Market
  • 16.4 New Liquid Biopsy Product Launches to Fuel Market Revenues
  • 16.5 Government Funds for Refining Cancer Detection Drives the Liquid Biopsy Market Growth
  • 16.6 Increasing Focus of Manufacturers on Research & Development Through Collaborations To bolster Growth of Liquid Biopsy Market

17. Global Liquid Biopsy Market - Challenges

  • 17.1 Limitations in Third-Party Payer Coverage to Restrict Liquid Biopsy Market
  • 17.2 Liquid Biopsy Clinical Utility Challenges
  • 17.3 Unclear Regulations on Laboratory Developed Tests (LDT) for Liquid Biopsy

List of Figures

List of Figures:

  • Figure 3-1: Global - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 3-2: Global - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 4-1: By Circulating Biomarker - Liquid Biopsy Market Share (Percent), 2016 - 2021
  • Figure 4-2: By Circulating Biomarker - Forecast for Liquid Biopsy Market Share (Percent), 2022 - 2030
  • Figure 4-3: By Product - Liquid Biopsy Market Share (Percent), 2016 - 2021
  • Figure 4-4: By Product - Forecast for Liquid Biopsy Market Share (Percent), 2022 - 2030
  • Figure 4-5: By Application - Liquid Biopsy Market Share (Percent), 2016 - 2021
  • Figure 4-6: By Application - Forecast for Liquid Biopsy Market Share (Percent), 2022 - 2030
  • Figure 4-7: By Clinical Application - Liquid Biopsy Oncology Market Share (Percent), 2016 - 2021
  • Figure 4-8: By Clinical Application - Forecast for Liquid Biopsy Oncology Market Share (Percent), 2022 - 2030
  • Figure 4-9: By End User - Liquid Biopsy Market Share (Percent), 2016 - 2021
  • Figure 4-10: By End User - Forecast for Liquid Biopsy Market Share (Percent), 2022 - 2030
  • Figure 4-11: By Sample Type - Liquid Biopsy Market Share (Percent), 2016 - 2021
  • Figure 4-12: By Sample Type - Forecast for Liquid Biopsy Market Share (Percent), 2022 - 2030
  • Figure 5-1: Global Liquid Biopsy - Circulating Tumor Cells (CTCs) Market (Million US$), 2016 - 2021
  • Figure 5-2: Global Liquid Biopsy - Forecast for Circulating Tumor Cells (CTCs) Market (Million US$), 2022 - 2030
  • Figure 5-3: Global Liquid Biopsy - Circulating Tumor DNA (ctDNA) Market (Million US$), 2016 - 2021
  • Figure 5-4: Global Liquid Biopsy - Forecast for Circulating Tumor DNA (ctDNA) Market (Million US$), 2022 - 2030
  • Figure 5-5: Global Liquid Biopsy - Cell-Free DNA (cfDNA) Market (Million US$), 2016 - 2021
  • Figure 5-6: Global Liquid Biopsy - Forecast for Cell-Free DNA (cfDNA) Market (Million US$), 2022 - 2030
  • Figure 5-7: Global Liquid Biopsy - Extracellular Vesicles (EVs) Market (Million US$), 2016 - 2021
  • Figure 5-8: Global Liquid Biopsy - Forecast for Extracellular Vesicles (EVs) Market (Million US$), 2022 - 2030
  • Figure 5-9: Global Liquid Biopsy - Other Circulating Biomarkers Market (Million US$), 2016 - 2021
  • Figure 5-10: Global Liquid Biopsy - Forecast for Other Circulating Biomarkers Market (Million US$), 2022 - 2030
  • Figure 6-1: Global Liquid Biopsy - Kits and Consumables Market (Million US$), 2016 - 2021
  • Figure 6-2: Global Liquid Biopsy - Forecast for Kits and Consumables Market (Million US$), 2022 - 2030
  • Figure 6-3: Global Liquid Biopsy - Instruments Market (Million US$), 2016 - 2021
  • Figure 6-4: Global Liquid Biopsy - Forecast for Instruments Market (Million US$), 2022 - 2030
  • Figure 6-5: Global Liquid Biopsy - Services Market (Million US$), 2016 - 2021
  • Figure 6-6: Global Liquid Biopsy - Forecast for Services Market (Million US$), 2022 - 2030
  • Figure 7-1: Global Liquid Biopsy - Oncology Application Market (Million US$), 2016 - 2021
  • Figure 7-2: Global Liquid Biopsy - Forecast for Oncology Application Market (Million US$), 2022 - 2030
  • Figure 7-3: Global - Lung Cancer Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 7-4: Global - Forecast for Lung Cancer Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 7-5: Global - Breast Cancer Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 7-6: Global - Forecast for Breast Cancer Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 7-7: Global - Colorectal Cancer Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 7-8: Global - Forecast for Colorectal Cancer Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 7-9: Global - Prostate Cancer Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 7-10: Global - Forecast for Prostate Cancer Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 7-11: Global - Gastrointestinal Cancer Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 7-12: Global - Forecast for Gastrointestinal Cancer Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 7-13: Global - Leukaemia Cancer Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 7-14: Global - Forecast for Leukaemia Cancer Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 7-15: Global - Others Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 7-16: Global - Forecast for Others Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 7-17: Global Liquid Biopsy - Non-Cancer Application Market (Million US$), 2016 - 2021
  • Figure 7-18: Global Liquid Biopsy - Forecast for Non-Cancer Application Market (Million US$), 2022 - 2030
  • Figure 8-1: Global Liquid Biopsy Oncology Application - Therapy Selection Market (Million US$), 2016 - 2021
  • Figure 8-2: Global Liquid Biopsy Oncology Application - Forecast for Therapy Selection Market (Million US$), 2022 - 2030
  • Figure 8-3: Global Liquid Biopsy Oncology Application - Treatment Monitoring Market (Million US$), 2016 - 2021
  • Figure 8-4: Global Liquid Biopsy Oncology Application - Forecast for Treatment Monitoring Market (Million US$), 2022 - 2030
  • Figure 8-5: Global Liquid Biopsy Oncology Application - Early Cancer Screening Market (Million US$), 2016 - 2021
  • Figure 8-6: Global Liquid Biopsy Oncology Application - Forecast for Early Cancer Screening Market (Million US$), 2022 - 2030
  • Figure 8-7: Global Liquid Biopsy Oncology Application - Recurrence Monitoring Market (Million US$), 2016 - 2021
  • Figure 8-8: Global Liquid Biopsy Oncology Application - Forecast for Recurrence Monitoring Market (Million US$), 2022 - 2030
  • Figure 9-1: Global Liquid Biopsy - Reference Laboratories Market (Million US$), 2016 - 2021
  • Figure 9-2: Global Liquid Biopsy - Forecast for Reference Laboratories Market (Million US$), 2022 - 2030
  • Figure 9-3: Global Liquid Biopsy - Hospitals and Physician Laboratories Market (Million US$), 2016 - 2021
  • Figure 9-4: Global Liquid Biopsy - Forecast for Hospitals and Physician Laboratories Market (Million US$), 2022 - 2030
  • Figure 9-5: Global Liquid Biopsy - Academic and Research Centers Market (Million US$), 2016 - 2021
  • Figure 9-6: Global Liquid Biopsy - Forecast for Academic and Research Centers Market (Million US$), 2022 - 2030
  • Figure 9-7: Global Liquid Biopsy - Other End Users Market (Million US$), 2016 - 2021
  • Figure 9-8: Global Liquid Biopsy - Forecast for Other End Users Market (Million US$), 2022 - 2030
  • Figure 10-1: Global Liquid Biopsy - Blood Sample Market (Million US$), 2016 - 2021
  • Figure 10-2: Global Liquid Biopsy - Forecast for Blood Sample Market (Million US$), 2022 - 2030
  • Figure 10-3: Global Liquid Biopsy - Urine Sample Market (Million US$), 2016 - 2021
  • Figure 10-4: Global Liquid Biopsy - Forecast for Urine Sample Market (Million US$), 2022 - 2030
  • Figure 10-5: Global Liquid Biopsy - Other Fluids Sample Market (Million US$), 2016 - 2021
  • Figure 10-6: Global Liquid Biopsy - Forecast for Other Fluids Sample Market (Million US$), 2022 - 2030
  • Figure 11-1: North America - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 11-2: North America - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 11-3: Asia Pacific - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 11-4: Asia Pacific - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 11-5: Europe - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 11-6: Europe - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 11-7: Latin America - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 11-8: Latin America - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 11-9: Middle East & Africa - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 11-10: Middle East & Africa - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 12-1: United States - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 12-2: United States - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 12-3: Canada - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 12-4: Canada - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 12-5: South Korea - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 12-6: South Korea - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 12-7: Japan - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 12-8: Japan - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 12-9: China - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 12-10: China - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 12-11: India - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 12-12: India - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 12-13: Australia - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 12-14: Australia - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 12-15: Rest of Asia Pacific - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 12-16: Rest of Asia Pacific - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 12-17: Germany - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 12-18: Germany - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 12-19: France - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 12-20: France - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 12-21: United Kingdom - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 12-22: United Kingdom - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 12-23: Italy - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 12-24: Italy - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 12-25: Spain - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 12-26: Spain - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 12-27: Rest of Europe - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 12-28: Rest of Europe - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 12-29: UAE - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 12-30: UAE - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 12-31: Saudi Arabia - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 12-32: Saudi Arabia - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 12-33: Egypt - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 12-34: Egypt - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 12-35: Rest of Middle East & Africa - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 12-36: Rest of Middle East & Africa - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
  • Figure 12-37: Latin America - Liquid Biopsy Market (Million US$), 2016 - 2021
  • Figure 12-38: Latin America - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030

List of Tables:

  • Table 4-1: By Cancer Types - Liquid Biopsy Oncology Market Share (Percent), 2016 - 2021
  • Table 4-2: By Cancer Types - Forecast for Liquid Biopsy Oncology Market Share (Percent), 2022 - 2030
  • Table 4-3: By Region - Liquid Biopsy Market Share (Percent), 2016 - 2021
  • Table 4-4: By Region - Forecast for Liquid Biopsy Market Share (Percent), 2022 - 2030
  • Table 4-5: By Country - Liquid Biopsy Market Share (Percent), 2016 - 2021
  • Table 4-6: By Country - Forecast for Liquid Biopsy Market Share (Percent), 2022 - 2030
  • Table 15-1: Clearbridge BioMedics - Distributors in EMEA and APAC Regions
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!